Bioengineering and Bioscience
In collaboration with various partners, transformative research is bringing together science, engineering, and clinical practice in unique ways to advance our understanding of disease processes and improve healthcare. As the life sciences have increasingly converged with engineering disciplines, Georgia Tech’s research in bioengineering and bioscience has grown dramatically over the past thirty years. Georgia Tech’s vision is to create an environment of innovation that will enable cross-disciplinary teams of researchers to tackle grand challenges in healthcare and biotechnology, and define new fields of scientific endeavor.
Through partnerships, Georgia Tech fosters interactions between local institutions Emory University, Children's Healthcare of Atlanta, Morehouse School of Medicine, the Shepherd Center, as well as other prominent institutions around the world, such as Peking University. Georgia Tech has built a large research portfolio in basic and applied disciplines by taking an interdisciplinary approach toward global health issues. Supported by Georgia Tech’s entrepreneurial tradition and strong technology transfer infrastructure, these efforts increasingly involve industry partnerships that help move research innovations into clinical applications.
Researcher Samirkumar Patel displays a prototype
microneedle used to inject therapeutics into specific
locations in the eye. The technology could allow doctors
to target drugs to locations in the eye that are now
difficult to reach. (Credit: Gary Meek) Full Story >
Since 1995, Georgia Tech has invested more than $200 million to create a four-building bioengineering and biosciences research complex with more than one million square feet of space and state-of-the-art core research facilities. Engineers of all varieties, biologists, chemists, physicists, computer scientists, mathematicians, and others housed in the complex partner on basic, applied and clinical research in a variety of areas to improve patient care and the quality of life. Our broad-based effort involves over 150 faculty and hundreds of trainees from across the entire campus.
Georgia Tech also plays a pivotal role in developing medical devices, biomaterials, regenerative medicine applications, pharmaceutical technologies, diagnostic devices, healthcare robotics and accessibility and rehabilitation tools, in addition to disease treatments and therapies designed to improve lives. Research into the origin, diagnosis, and treatment of cancer is a major part of this effort.
Advances in bio-related research are important to improving human conditions throughout the world. Georgia Tech will continue to focus on developing next-generation solutions to bioengineering and bioscience grand challenges.
